Rat Bone Marrow Mesenchymal Stem Cells (BMSCs) Inhibit Liver Fibrosis by Activating GSK3β and Inhibiting the Wnt3a/β-Catenin Pathway

Researchers investigated the antifibrotic effects of bone marrow MSCs and elucidated the underlying mechanism by which BMSCs affect liver fibrosis in vitro and in vivo.